Boockvar KS, et al. - Researchers conducted an observational cohort study at all US nursing homes (NHs) in order to determine patterns of antihypertensive medication treatment in NH residents treated for hypertension, with and without moderate or severe cognitive impairment. in addition, they assessed the association between antihypertensive treatment and outcomes important to individuals with dementia. They identified 255,670 NH residents who were treated for hypertension; of these, 117,732 (46.0%) had moderate or severe cognitive impairment. At baseline, there were 54.4%, 34.3%, and 11.4% of patients who were receiving one, two, and three or more antihypertensive medications, respectively. They observed moderate or severe cognitive impairment, worse physical function, and hospice or less than a 6-month life expectancy in correlation with receipt of fewer antihypertensive medications. The analysis revealed no significant benefit of more intensive antihypertensive treatment among long-term NH residents with hypertension. They suggest antihypertensive medications as probable targets for deintensification in residents in whom this is consistent with goals of care.